Jane Street Group, LLC Evolus, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$5.22 - $11.78 $241,686 - $545,414	-46,300 Reduced 66.24%	23,600 $265,000
Q4 2021 Feb 15, 2022	SELL	$5.37 - $8.38 $339,921 - $530,454	-63,300 Reduced 47.52%	69,900 $455,000
Q3 2021 Nov 16, 2021	SELL	$7.36 - $13.67 $823,584 - $1.53 Million	-111,900 Reduced 45.65%	133,200 $1.02 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $1.22 Million - $2.02 Million	144,700 Added 144.12%	245,100 $3.1 Million
Q1 2021 May 18, 2021	BUY	$3.2 - $16.51 $270,080 - $1.39 Million	84,400 Added 527.5%	100,400 $1.3 Million
Q3 2020 Nov 17, 2020	SELL	$3.03 - $5.48 $42,420 - $76,720	-14,000 Reduced 46.67%	16,000 $63,000
Q2 2020 Aug 17, 2020	BUY	$3.53 - $6.17 $105,900 - $185,100	30,000 New	30,000 $159,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.